YY1 and colorectal carcinoma: Through a methylated DNA immunoprecipitation‐chip analysis of a paired CRC and adjacent normal tissues, YY1 was also screened to be one of the prominent transcription factors (TFs) with aberrant promoter hypomethylation which might be responsible for its high expression level and tumorigenesis function.30